Roser Calvo
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 10
- Chronic Lymphocytic Leukemia Research 9
- Congenital Ear and Nasal Anomalies 1
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Harry A. Drabkin (4 shared papers)James West (2 shared papers)Paul A. Erickson (2 shared papers)Rafael Rosell (2 shared papers)Robert M. Gemmill (2 shared papers)Joëlle Roche (1 shared paper)Wilbur A. Franklin (1 shared paper)Barbara A. Helfrich (1 shared paper)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)Blood Advances (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesSpainPoland
In The Last Decade
Roser Calvo
17 papers receiving 404 citations
Peers
Comparison fields: 5 of 49
- Genetics 54
- Pathology and Forensic Medicine 89
- Cancer Research 62
- Oncology 100
- Otorhinolaryngology 14
Countries citing papers authored by Roser Calvo
This map shows the geographic impact of Roser Calvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roser Calvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roser Calvo more than expected).
Fields of papers citing papers by Roser Calvo
This network shows the impact of papers produced by Roser Calvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roser Calvo. The network helps show where Roser Calvo may publish in the future.
Co-authors
The 25 scholars most cited alongside Roser Calvo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 169 | |
| 2 | 1997 | 50 | |
| 3 | 1999 | 42 | |
| 4 | 2019 | 39 | |
| 5 | 2022 | 25 | |
| 6 | 2000 | 18 | |
| 7 | 1983 | 16 | |
| 8 | 2021 | 11 | |
| 9 | 1998 | 10 | |
| 10 | 2024 | 9 | |
| 11 | 2000 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2015 | 1 |
About Roser Calvo
Roser Calvo is a scholar working on Genetics, Pathology and Forensic Medicine, Molecular Biology, Oncology and Dermatology, having authored 17 papers that have together received 412 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Cutaneous lymphoproliferative disorders research (2 papers), CAR-T cell therapy research (2 papers), RNA Research and Splicing (2 papers), Congenital Ear and Nasal Anomalies (1 paper), DNA Repair Mechanisms (1 paper) and Platelet Disorders and Treatments (1 paper). The work is most often cited by research in Genetics (54 citations), Pathology and Forensic Medicine (89 citations), Cancer Research (62 citations), Oncology (100 citations) and Otorhinolaryngology (14 citations). Roser Calvo has collaborated with scholars based in United States, Spain and Poland. Frequent co-authors include Harry A. Drabkin, James West, Paul A. Erickson, Rafael Rosell, Robert M. Gemmill, Joëlle Roche, Wilbur A. Franklin, Barbara A. Helfrich, Lynne Bemis and Élisabeth Brambilla. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Blood Advances and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.